Abstract Improved survival for haemodialysis patients with dialyser ultrafiltration coefficients exceeding has been reported for synthetic, high-flux biocompat-15-20 ml/mmHg/h. The improved outcomes for ible membranes. The reported data fail to answer the patients dialysed on these membranes could reflect question whether improved survival is related to an improved biocompatibility [7] or increased clearance effect of enhanced biocompatibility or to increased of uraemic toxins of larger molecular size not cleared clearance of larger molecular species of putative by low-flux dialysers [8] [9] [10]. A recent report from the uraemic toxins. A retrospective analysis of 715 patients Italian Dialysis Study Group [11] failed to resolve this treated by continuous haemodialysis for up to 5 years issue despite a study design intended to separate the was undertaken. Low-flux polysulfone dialysis was effects of the biocompatibility and the convective effects used exclusively for 252 patients and 463 patients were of different treatment strategies. exposed for at least 3 months to high-flux polysulfone
Introduction
large molecules associated with larger membrane surface area and the maintenance of large values of total There is increasing evidence that all cause-specific blood processed per session by high blood flow rate. mortality and hospitalization rates are lower for Modern high-flux dialysers associated with volumetrichaemodialysis patients treated with synthetic mem-controlled ultrafiltration and bicarbonate dialysis bring branes compared with those for patients dialysed with these objectives within reach [14, 15] . cellulosic membranes [1] [2] [3] [4] [5] [6] . In these studies the Whereas much attention has been devoted to the application of synthetic and modified cellulosic benefits of the enhanced biocompatibility profiles of biocompatible membranes included high-flux dialysis synthetic and semisynthetic high-flux dialyser mem-membranes provided by a single manufacturer. The (median age 47 vs 41 years) and included 97 of the 113 patients older than 60 years. Seventy-one of the patients were divided into two groups according to whether they had received high-flux dialysis for at least 75 diabetics included in the study were in group 2.
Group 2 also included more patients with systemic 3 months. Analysis of outcomes for these patients indicates a significant benefit for high-flux dialysis and lupus nephritis (28 vs 5). Comorbidity was defined as any major non-renal disease; most patients diagnosed suggests that permselectivity is an independent factor in the improved outcomes for patients dialysed with as having a comorbid factor had historical or currently active ischaemic heart disease or cerebrovascular dishigh-flux membranes.
ease or diabetes not causative of kidney failure. Of 56 patients with one or more comorbid factors 49 were
Patients and methods
included in group 2.
Choice of dialyser membrane Dialysis programme and protocols Cellulosic dialysers were abandoned in this programme The programme is a stand-alone haemodialysis (HD) by the end of 1990 and since then all dialyses have programme with no hospital affiliation. In January been conducted with polysulfone dialysers (Fresenius, 1991 HD therapy was provided at four HD satellite Germany). Over the years of the study empirical centres. By the end of the study period (31/06/96) nine guidelines have been developed for the use of high-flux satellite centres were operational. On average a dialysis dialysis. Patients most likely to be prescribed high-flux centre comprised 15 dialysis stations operating three dialysis include diabetics, patients older than 60 years, patient shifts per day and weekly patient census ranged patients with cardiac, cerebrovascular or peripheral from 5 to 5.7 patients per dialysis station. vascular disease or other major non-renal organ disWater for dialysate production and dialyser reproease, patients experiencing a catabolic event (e.g. major cessing was produced by standard central pretreatment surgery, infection) and any patient deemed to have and reverse osmosis. Water and dialysate endotoxin failed to thrive after 3-6 months of low-flux dialysis. levels by LAL assay were consistently less than 0.25 In general, once a patient was converted to high-flux EU/ml. dialysis they were unlikely to revert to low flux.
All than patients in group 1. Group 2 patients were older H. F. Woods and M. Nandakumar 38 USA) and using peracetic acid-hydrogen peroxide analyse data means the possibility of time dependency of one or more variables was negated. (Puristeril: Fresenius) as rinse and sterilant reagent.
Dialysis prescription for solute removal was based on the Kt/V index. Patient volume was estimated from Statistical analysis Watson's formula. The value of K (dialyser urea clear-All statistical analyses were performed using the SPSS ance) was estimated from manufacturer's data for mass version 6.1 software package [17] . transfer coefficient for urea ( KoA) and from calculated Difference for proportions was analysed by the Chiblood-water flow rate (Qbw). Correction of blood-square test. Difference for means of continuous variflow rate to blood-water flow rate imposes a more ables was analysed using a two-tailed Student's t-test conservative estimate of dialyser urea clearance. A without assumption of equal variance. Probability of minimum target Kt/V of 1.2 was prescribed for all survival was calculated using the Kaplan-Meier patients. All patients with the exception of one male method [18] with death as the determinant event. aged 87 years dialysed thrice weekly. Few patients Patients were censored either at the end of the study admitted daily urine output exceeding 300 ml ('two (31/03/96), date of transplantation or date of loss-tocupfulls') and residual renal function was assumed to follow-up [transfer to other provider, conversion to be negligible for all patients.
continuous ambulatory peritoneal dialysis (CAPD), Every 2 months the following data were captured etc.]. Statistical difference between groups was estimand recorded for each mid-week dialysis (index dia-ated by the log rank test. Standardized mortality ratio lyses): pre-and postdialysis weight, predialysis systolic was calculated according to the method described by and diastolic BP, dialyser used, dialysis time (min), Wolfe et al. [19] with the Asian-American cohort of blood flow (Qb: ml/min). For the same dialysis session haemodialysis patients in 1995 as reference populablood samples were taken for pre-and postdialysis tion [20] . serum urea and serum creatinine, predialysis serum
The Cox proportional hazards regression model [21] albumin and blood haemoglobin. Predialysis blood was applied to estimate the independent impact of samples were decanted directly at the time of needle covariates on the time of death. Two models were insertion and before heparinization. Postdialysis blood generated; one included and the other excluded diabetic samples were taken from the 'arterial' needle after patients. Covariates were entered stepwise and included removal of the arterial blood line at the end of dialysis age at the time of entry to the programme, diagnosis and prior to saline washback. The volume of the needle (categorical: diabetic vs non-diabetic), comorbidity deadspace was flushed several times prior to aspiration (categorical: one-or-more vs no comorbid factors), of the sample; the procedure is completed~2 min predialysis creatinine, serum albumin, blood haemoafter completion of dialysis. This interval is likely to globin, dialyser flux (categorical: HF vs LF ), minimize any possible impact of vascular access or mid-week mean arterial pressure (predialysis) and cardiovascular recirculation on estimation of Kt/V. mid-week ultrafiltered fluid (kg). The mean of achieved Patients were encouraged to partake of an ad libitum Kt/V was entered as a continuous variable after transdiet with restriction only of selected local fruits high formation ( Kt/V×10). Examination of the Cox regresin potassium, and lentils, pulses and dairy products sion model stratified for membrane flux status as a high in phosphate content.
log-minus-log survival plot confirmed that the hazard ratio for flux status was parallel and proportional over the time of the study.
Data management
Patient demographic and diagnostic data, and clinical Results and laboratory data relevant to the index dialysis sessions were maintained in computer databases. By 31/6/96, 39 patients (5.4%) had died, 106 (15%) Greater than 98% data integrity has been achieved had received a renal transplant and 18 converted to since 1991. Through address to the database it was CAPD or were lost to follow-up (usually indicating possible to calculate mean values for the index dialysis transfer to another provider programme but including sessions for pre-and postdialysis weight, blood pres-withdrawals for other reasons). Transplantation, sure, dialysis session time, serum urea and serum deaths and other losses were all more common in creatinine. Mean values for intradialysis weight loss group 1 than group 2 ( Table 2) . Information on cause ( UF: kg), mean arterial pressure (MAP: mmHg), ratio of death was rarely provided by the referring centre or of postdialysis to predialysis urea [r] and urea reduction hospital where death occurred denying the possibility ratio ( URR) were calculated. Achieved Kt/V was of analysis of cause-specific death. calculated using the logarithmic formula described by Daugirdas [16 ] , which includes correction for convect-Biochemical parameters ive urea clearance and intradialysis urea generation. Mean values were also calculated for predialysis serum Selected clinical and biochemical parameters for the albumin, blood haemoglobin. For over 95% of patients two patients groups are listed in Table 3 . Both groups data from more than three dialysis sessions were avail-had the same predialysis mean arterial pressure and did not differ in weight or height. Mean blood flow able for calculation of mean values. By choosing to
Comparison of outcomes for high-and low-flux polysulfone dialysis 39 rates and duration of dialysis session were similar for both groups. Patients on high-flux dialysis had a marginally, but significantly, higher Kt/V than lowflux patients. The higher mean value for predialysis urea for high-flux patients who also achieved a higher mean Kt/V suggests that group 2 patients had a higher dietary protein intake than patients in group 1. Lower serum albumin and serum creatinine values for highflux patients are consistent with the higher risk status of this patient group based on older age and greater frequency of diabetes and comorbid conditions. Values for blood haemoglobin, serum phosphates and total CO 2 were similar for both groups. The mortality of this patient population is less than for various matched aged groups ranged from 0.13 to that reported by most national registries. The USRDS 0.46 for non-diabetic patients and from 0.3 to 0.9 for Annual Data Report of 1997 [20] reports lower mortaldiabetic patients (data not shown). Both patient groups ity for Asian-American haemodialysis patients than had significantly lower SMR than the American referfor other ethnic groups and we chose this cohort as ence population and group 2 patients had a significthe reference population suspecting that it most closely antly lower SMR than group 1 (0.13 vs 0.2 respectively; matches our patients for body size and other relevant P=0.012). Overall mortality (deaths per 1000 years characteristics. Standardized mortality ratios (SMR) risk) was higher in group 1 than group 2 patients (36 vs 21) ( Table 2 ). When diabetic patients were excluded from the analysis probability of survival ( Kaplan-Meier) was signi- H. F. Woods and M. Nandakumar 40 group 2 patients there was no significant difference in survival. The data available to us do not permit quantification of such a difference and the point is survival ( log rank=0.34; P=0.56) .
moot. The extremely low overall mortality reported here indicates that either by constitution or by nature Predictors of mortality of the treatment provided (e.g. the high Kt/V relatively The output of the Cox proportional hazards models easily delivered to these small patients) this patient are shown in Tables 4 and 5 . Serum albumin, blood cohort is unusual and it may be that our results cannot haemoglobin, mean arterial pressure and mid-week reasonably be extrapolated to other patients. ultrafiltered volume had no impact on risk of death in
The results reported here indicate that high-flux either model. When diabetic patients were included in dialysis confers a significant benefit in terms of patient the model age, diabetes, comorbidity, dialysis dose survival compared with low-flux dialysis. The impact ( Kt/V ) and predialysis creatinine all had significant of high-flux dialysis is more convincing since patients impact upon the relative risk of death. As a covariate receiving high-flux dialysis were at distinctly greater dialyser flux just failed to reach significance (P=0.069). risk than patients treated by low-flux dialysis. Having In contrast, when diabetic patients were excluded from abandoned the use of cellulosic membranes by the end the model comorbidity ceased to have a significant of 1990 we have, over the years covered by the study, effect upon relative risk. Age at entry, dialysis dose evolved empirical guidelines for prescribing high-flux and predialysis creatinine retained similar effects upon dialysis (see Patients and Methods). In summary, highrelative risk of death and high-flux dialysis was associ-flux dialysis was selected for patients at greater risk ated with a 66% reduction in risk of death (CI 15-85%). for whatever reason as shown in Table 1 with a majority of diabetic, elderly and patients with comorbidity allocated to the high-flux group.
Discussion
We recognize the limitations of the statistical methods used here ( Kaplan-Meier probability of surThe 715 consecutive haemodialysis patients reported vival and Cox's proportional hazards model ) when the here comprise a relatively low-risk population, median number of events is low and this defect may be age 47 years and prevalence of diabetic nephropathy magnified when analysing subgroups. Retrospective less than 12% and, overall, experience 5-year survival analysis such as this cannot expect to approach the (86%) equalling or surpassing that of any other sensitivity of prospective randomized studies but these reported haemodialysis population including that from are, at present, lacking on the specific issue of whether Tassin [12] . dialyser flux affects patient outcomes when controlled The analysis is unique in reporting a large cohort of for membrane biocompatibility. These reservations patients treated exclusively with a single membrane aside, the results reported here suggest that high-flux type (polysulfone) but permitting the comparison of dialysis negates partially the probability of death outcomes for patients exposed and not exposed to associated with older age and reduces the relative risk high-flux dialysis. Furthermore, the two groups of of death, at least in non-diabetic patients. patients were treated contemporaneously and by the These data support other reports in the literature same clinical team under a single management. It is associating superior outcomes for haemodialysis possible that, since by selection high-flux dialysis was patients treated with biocompatible synthetic and prescribed for higher risk patients, other aspects of modified cellulosic membranes when compared with outcomes for patients treated on unmodified cellulosic patient care differed for the two groups and affected 
